Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and Circulating Microparticles in Type 1 Diabetes Mellitus [PDF]
Background and Aim: Hyperglycemia in type 1 diabetes (T1D) is accompanied by endothelial cell dysfunction which is known to contribute to the pathogenesis of cardiovascular disorders. The aim of the current study was to explore the profile of circulating
Asmaa M. Zahran MD +7 more
doaj +6 more sources
High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity [PDF]
: Background: Behçet's disease is a multisystemic vasculitis, associated with vascular endothelial dysfunction. Currently, the prognosis is unpredictable, because there is still no valid laboratory marker indicating the disease activity in Behçet's ...
Deniz Aksu Arica +5 more
doaj +3 more sources
Cancer, a proliferative disease hallmarked by abnormal cell growth and spread, is largely dependent on tumor neoangiogenesis, with evidence of vascular endothelial dysfunction.
P.K.Y. Goon +4 more
doaj +5 more sources
Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells [PDF]
Background— Transplantation of ex vivo expanded circulating endothelial progenitor cells (EPCs) from peripheral blood mononuclear cells improves the neovascularization after critical ischemia. However, the origin of the endothelial progenitor lineage and
Carmen Urbich +5 more
core +5 more sources
Pulmonary arterial hypertension in children with congenital heart disease: a deeper look into the role of endothelial progenitor cells and circulating endothelial cells to assess disease severity [PDF]
Endothelial progenitor cells and circulating endothelial cells have been proposed as useful markers of severity and disease progression in certain vascular diseases, including pulmonary arterial hypertension. Our study focused on evaluating the levels of
Juan Calderón-Colmenero +10 more
doaj +2 more sources
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19. [PDF]
Beside the commonly described pulmonary expression of the coronavirus disease 2019 (COVID-19), major vascular events have been reported. The objective of this study was to investigate whether increased levels of circulating endothelial cells (CEC) might ...
Guervilly C +20 more
europepmc +2 more sources
Circulating endothelial cells after transplantation [PDF]
Fate of renal allografts that survive vascular rejection To measure the outcome for grafts that survive early vascular rejection, we reassessed 411 biopsy samples taken from 260 patients in the first month after transplantation. Patients were separated into four classifications, according to Banff 1997 criteria: vascular rejection (36 patients); acute
Salazar, A. B. +3 more
exaly +12 more sources
Intermediate Monocytes and Circulating Endothelial Cells: Interplay with Severity of Atherosclerosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus [PDF]
The aim was to investigate the association of monocyte heterogeneity and presence of circulating endothelial cells with the severity of coronary atherosclerosis in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM).
Irina V. Kologrivova +7 more
doaj +2 more sources
Circulating endothelial cells in COVID-19. [PDF]
No abstract ...
Nizzoli ME +12 more
europepmc +5 more sources
Circulating endothelial cells as biomarker for cardiovascular diseases. [PDF]
Endothelial dysfunction is involved in several cardiovascular diseases. Elevated levels of circulating endothelial cells (CECs) and low levels of endothelial progenitor cells (EPCs) have been described in different cardiovascular conditions, suggesting ...
Farinacci M +7 more
europepmc +2 more sources

